Drug Profile
BMS 986147
Alternative Names: BMS-986147Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Immunological-disorders(In volunteers) in USA (PO)
- 01 Oct 2014 Phase-I clinical trials in Immunological disorders (In volunteers) in USA (PO)